In the BioHarmony Drug Report Database

"Preview" Icon

Tedizolid

Sivextro (tedizolid) is a small molecule pharmaceutical. Tedizolid was first approved as Sivextro on 2014-06-20. It is used to treat bacterial infections, bacterial skin diseases, staphylococcal infections, and streptococcal infections in the USA. It has been approved in Europe to treat bacterial skin diseases and soft tissue infections. Sivextro’s patents are valid until 2030-12-31 (FDA).

 

Trade Name

 

Sivextro
 

Common Name

 

tedizolid
 

ChEMBL ID

 

CHEMBL1257051
 

Indication

 

bacterial infections, bacterial skin diseases, soft tissue infections, staphylococcal infections, streptococcal infections
 

Drug Class

 

Oxazolidinone antibacterials

Image (chem structure or protein)

Tedizolid structure rendering